MELAS: Monitoring treatment with Magnetic Resonance Spectroscopy.

Serial MRS imaging showed significant improvement in lactate peaks and NAA/Cho ratios that corresponded with clinical improvement after L-arginine therapy. Given this correlation between radiologic and clinical improvement, MRS may be a useful biomarker assessing response to treatment in MELAS. This article is protected by copyright. All rights reserved.